Coronavirus iRNA compositions and methods of use thereof
US11208660B1 · kind B1 · utility
1Cited by
0References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 17, 2021 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | May 17, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the coronavirus genome. The invention also relates to methods of using such RNAi agents to inhibit expression of a coronavirus genome and to methods of treating or preventing a coronavirus-associated disease in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.